Gross N, Balmas Bourloud K, Brognara C B
Onco-Hematology Unit, University Hospital CHUV, Lausanne, 1011, Switzerland.
Exp Cell Res. 2000 Nov 1;260(2):396-403. doi: 10.1006/excr.2000.5007.
Highly malignant neuroblastoma tumors with MYCN amplification have been shown to downregulate the expression of the CD44 adhesion receptor. We have previously shown that MYCN amplified neuroblastoma cell lines either lack CD44 expression or express a nonfunctional, nonhyaluronic acid-binding CD44 receptor. By analysis of cells with manipulated expression of either CD44 or MYCN, we demonstrate that transfection of cells with a CD44 full-length cDNA construct produced a functional receptor in single copy MYCN cells and a nonfunctional CD44 receptor in MYCN amplified cells, similar to the CD44 receptor expressed by cells with enforced MYCN. Analysis of the in vivo growth properties of the transfectants revealed that the restoration of a functional CD44 receptor in nonamplified cells resulted in the suppression of in vivo cell growth, therefore linking the MYCN-related lack of hyaluronic acid-binding function of CD44 to the highly tumorigenic properties of a subset of neuroblastoma cells.
已证明,具有MYCN扩增的高恶性神经母细胞瘤肿瘤会下调CD44黏附受体的表达。我们之前已表明,MYCN扩增的神经母细胞瘤细胞系要么缺乏CD44表达,要么表达一种无功能、不结合透明质酸的CD44受体。通过对CD44或MYCN表达受到调控的细胞进行分析,我们证明,用CD44全长cDNA构建体转染细胞,在单拷贝MYCN细胞中产生了功能性受体,而在MYCN扩增细胞中产生了无功能的CD44受体,这与强制表达MYCN的细胞所表达的CD44受体相似。对转染子体内生长特性的分析表明,在未扩增细胞中恢复功能性CD44受体可导致体内细胞生长受到抑制,因此将MYCN相关的CD44缺乏透明质酸结合功能与一部分神经母细胞瘤细胞的高致瘤特性联系了起来。